Toxicology Education Day

Friday, March 23, 2018, 7:30 AM - 5:00 PM, Nicholson Tower Auditorium, OU Health Sciences Center, 940 NE 13th Street, 5th Floor


Toxicology Day is a single day conference targeting healthcare professionals that often care for patients with overdoses, envenomations, or other exposures. This includes: emergency medicine, critical care, family medicine, and internal medicine physicians and mid-level providers, pediatricians, pharmacists, and nurses. The activity will take place on the OUHSC campus and will entail both breakfast and lunch with afternoon snacks provided also. The content is described elsewhere but will be provided by content experts employed by the Oklahoma Center for Poison & Drug Information or the OU College of Pharmacy (geriatric content expert). Topics include: an introduction to the poison center and careers in toxicology, the general approach to the poisoned patient, toxic time bombs, toxicology in the news, emerging drugs of abuse, an antidote update, household products, over-the-counter products, cardiotoxic drugs, natural toxins, and pediatric/geriatric considerations. There will be a patient case and case-based lectures throughout.

1. Identify the tools and resources offered by the local poison control center.
2. Recognize the various professional paths available in regard to toxicology.
3. Recognize toxidromes based on initial physical examination findings.
4. Identify toxins known to cause delayed onset or recurrent toxicity.
5. Develop an appropriate management strategy for the acutely poisoned patient.
6. Describe emerging trends regarding toxicology in 2017-2018.
7. Identify emerging threats to children in regard to toxic substances.
8. Identify trends in illicit drug use in Oklahoma.
9. Analyze a patient presentation to develop a toxicology differential diagnosis
10. Name antidotes approved by the FDA in 2017-2018
11. Classify these antidotes based upon their indications for use in toxicity
12. Identify life-threatening exposures from household products
13. Identify life-threatening exposures from over-the-counter medications
14. Select the appropriate treatment modalities for a patient case
15. Describe the mechanisms by which cardiotoxins have their effects
16. Develop a treatment strategy for patients poisoned by a cardiotoxin
17. Identify the native venomous species of Oklahoma
18. Identify a treatment strategy to manage a patient envenomed by a pit viper
19. List key differences in management of pediatric and geriatric poisoned patients

Discounted Rates for OUHSC:

$75.00 - Faculty

$50.00 - Staff/Other Health Care Providers

$25.00 - Fellows, Residents, and Students

Regular Registration Fee (After March 5) 

$250 - Physicians (MD, DO, Fellows)
$150 - Other Healthcare Providers (NP, PharmD, etc…)
$125 - Residents
$75 -  PharmD Residents
$50 - Students

Residents and Students:  Please contact Jami Johnson (405) 271-5454 x 37020 or [email protected]u to receive a promo code for the special rates. 

ACCME/AMA PRA Category 1 Credit^TM 
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical   Education (ACCME) through the joint providership of the University of Oklahoma College of Medicine and the University of Oklahoma College of Pharmacy. The   University of Oklahoma College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Oklahoma College of Medicine designates this live activity for a maximum of 8.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacy Continuing Education:
The University of Oklahoma College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The University of Oklahoma offers 8.0 contact hours (0.8 CEU’s) of ACPE-accredited continuing pharmacy education credit accepted by the Oklahoma Board of Pharmacy and most other states requiring continuing education. Please note next to the listed ACPE # the type of activity [(K) = Knowledge-based CPE activity, (A) = Application=based CPE Activity]. For more information on activity types, please contact the University of Oklahoma College of Pharmacy at 405-271-6194. The program is designed as individual educational units and should be divided as noted in program materials. The University of Oklahoma College of Pharmacy records all credits granted and will retrieve records upon request. Credit will be available online to participants within four to six weeks upon verification of successful completion of the program. A notification email will be sent to participants when the statement of credit is ready. Credit for the program is awarded only for full participation and attendance is verified through official sign-in at the beginning of the session, the completion of the online program evaluation, the return of your nametag, NABP e-Profile ID # and the month and day of your birth. Initial release date of 03/23/2018.

Enrollment Procedures/Registration Fees/Refund and Grievance Policy:
Pre-registration is required to allow the College to provide the appropriate faculty and materials necessary to meet the program objectives. Registrations will be accepted until 03/23/18. OCPDI reserves the right to limit registrations or cancel courses if registration is insufficient.  There will be no refunds granted.  Participants are encouraged to contact the Office of Alumni Affairs at 405-271-6194 by 03/16/18 to confirm the status of the program.  For any grievance associated with this educational activity, please notify the Continuing Education Administrator.  You may contact the Office of Continuing Pharmaceutical Education for a copy of Grievance Policies. 

_{Nursing Continuing Education:} 
The University of Oklahoma Fran and Earl Ziegler College of Nursing is an approved provider of continuing education by the Western Multi-State Division, an accredited approver by the  American Nurses Credentialing Center’s Commission on Accreditation. (Certificate #UOKCON-1019-Approval active August 22, 2016-October 1, 2019). The University of Oklahoma College of Nursing CE Department designates this live activity for a maximum of 8.0 Nursing CEs. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Disclaimer Statement:
Statements, opinions and results of studies contained in the program are those of the presenters and authors and do not reflect the policy or position of the Board of Regents of the University of Oklahoma (“OU”) nor does OU provide any warranty as to their accuracy or reliability. Every reasonable effort has been made to faithfully reproduce the presentations and material as submitted. However, no responsibility is assumed by OU for any claims, injury and/or damage to persons or property from any cause, including negligence or otherwise, or from any use or  operation of any methods, products, instruments or ideas contained in the material herein.

Conflicts of Interest: 
 This educational activity does not include any content that relates to the products and/or services of a commercial interest that would create a conflict of interest. No individuals in a position to control content for this activity have relevant financial relationships to declare. It is the policy of the University of Oklahoma, College of Medicine that the  faculty and presenters disclose real or apparent conflicts of interest relating to  the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentations.

Conflict Resolution Statement:
The University of Oklahoma College of Medicine, Office of Continuing Professional Development has reviewed this activity’s speaker and planner disclosures and resolved all identified conflicts of interest, if applicable.

Nondiscrimination Statement:
The University of Oklahoma, in compliance with all applicable federal and state laws and regulations does not discriminate on the basis of race, color, national origin, sex, sexual orientation, genetic information, gender identity, gender expression, age religion, disability, political beliefs, or status as a veteran in any of its policies, practices, or procedures. This includes, but is not limited to: admissions, employment, financial aid, and educational services. Inquiries regarding non-discrimination policies may be directed to: Bobby J. Mason, University Equal Opportunity Office and Title IX Coordinator, (405) 325-3546, [email protected], or visit www.ou.edu/eoo.

Accommodation Statement: 
For accommodation, contact Jami Johnson at (405) 271-5454 or ([email protected]).

Policy on Faculty, Joint Provider and Presenters Disclosure: 
It is the policy of the University of Oklahoma, College of Medicine that the faculty, presenters and joint provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s).  

Enrollment Procedures/Registration Fees/Refund and Grievance Policy:
Pre-registration is required to allow the College to provide the appropriate faculty and materials necessary to meet the program objectives. Registrations will be accepted until 03/23/18.  OCPDI reserves the right to limit registrations or cancel courses if registration is insufficient.  There will be no refunds granted.  Participants are encouraged to contact the Office of Alumni Affairs at 405-271-6194 by 03/16/18 to confirm the status of the program.  For any grievance associated with this educational activity, please notify the Continuing Education Administrator.  You may contact the Office of Continuing Pharmaceutical Education for a copy of Grievance Policies.

AMA PRA Category 1 Credits™ (8.00 hours), ANCC Nursing Contact Hours (8.00 hours), Non-Physician Attendance (8.00 hours)

Planning Committee Members

   Jami Johnson, PharmD, DABAT 
                     Course Director

  Steven A. Crawford, MD

  Jeana Wilcox, RN, PhD

   Myrna Rae Page, MPH, CHES

  Margie Miller, MS, CPP

   Sandra Warner

   Kristie Williams, PharmD, CSPI  

  Estzer Moore, PharmD candidate

Planning committee disclosures and resolutions will be available in the course syllabus.

 

Friday, March 23, 2018

Acknowledgement of Commercial and In-Kind Support: 
Commercial Support:  is financial, or in-kind, contributions given by a commercial interest, which is used to pay all or part of the costs of a CME  activity.  A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on,  patients.

This activity is made possible by an unrestricted educational grant from BTG  International, Inc.